Neogen Corp
NEOG4.650USD
-0.045-0.96%
Handelsschluss 07/31, 16:00（ET）Kurse um 15 Minuten verzögert
1.01BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Neogen Corp Unternehmen
Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
Unternehmensinformationen
BörsenkürzelNEOG
Name des UnternehmensNeogen Corp
IPO-datumAug 23, 1989
Gegründet am1981
CEOMr. John Edward Adent
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeAug 23
Addresse620 Lesher Pl
StadtLANSING
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl48912
Telefon15173729200
Websitehttps://www.neogen.com/
BörsenkürzelNEOG
IPO-datumAug 23, 1989
Gegründet am1981
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John Edward Adent
Mr. John Edward Adent
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.28K
+0.78%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
124.19K
+73.77%
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
90.47K
+255.16%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
80.44K
+118.27%
Dr. William T. (Bill) Boehm, Ph.D.
Dr. William T. (Bill) Boehm, Ph.D.
Independent Director
Independent Director
35.59K
+16.34%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
27.99K
+133.42%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
13.24K
+77.20%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
12.78K
+46.92%
Ms. Andrea F. Wainer
Ms. Andrea F. Wainer
Independent Director
Independent Director
6.09K
--
Mr. Thierry Bernard
Mr. Thierry Bernard
Independent Director
Independent Director
5.62K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John Edward Adent
Mr. John Edward Adent
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.28K
+0.78%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
124.19K
+73.77%
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
90.47K
+255.16%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
80.44K
+118.27%
Dr. William T. (Bill) Boehm, Ph.D.
Dr. William T. (Bill) Boehm, Ph.D.
Independent Director
Independent Director
35.59K
+16.34%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
27.99K
+133.42%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Culture Media & Other
77.74M
35.18%
Bacterial & General Sanitation
39.88M
18.05%
Rodenticides, Insecticides & Disinfectants
35.64M
16.13%
Genomics Services
22.70M
10.27%
Natural Toxins, Allergens & Drug Residues
17.59M
7.96%
Other
27.41M
12.41%
Nach RegionUSD
Name
Umsatz
Anteil
Domestic
115.36M
52.21%
International
105.61M
47.79%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Culture Media & Other
77.74M
35.18%
Bacterial & General Sanitation
39.88M
18.05%
Rodenticides, Insecticides & Disinfectants
35.64M
16.13%
Genomics Services
22.70M
10.27%
Natural Toxins, Allergens & Drug Residues
17.59M
7.96%
Other
27.41M
12.41%
Aktionärsstatistik
Aktualisiert: 22 hours ago
Aktualisiert: 22 hours ago
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.19%
The Vanguard Group, Inc.
10.83%
William Blair Investment Management, LLC
4.33%
Baillie Gifford & Co.
4.22%
Gates Capital Management, Inc.
4.22%
Other
63.21%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.19%
The Vanguard Group, Inc.
10.83%
William Blair Investment Management, LLC
4.33%
Baillie Gifford & Co.
4.22%
Gates Capital Management, Inc.
4.22%
Other
63.21%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
64.46%
Investment Advisor/Hedge Fund
43.57%
Hedge Fund
6.03%
Sovereign Wealth Fund
4.26%
Research Firm
3.39%
Pension Fund
1.74%
Bank and Trust
1.03%
Individual Investor
0.41%
Private Equity
0.31%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
712
280.17M
129.09%
-8.82M
2025Q1
753
280.62M
129.30%
-9.42M
2024Q4
764
265.86M
122.55%
-15.84M
2024Q3
778
258.29M
119.19%
-21.39M
2024Q2
791
255.45M
117.89%
-8.15M
2024Q1
783
241.86M
111.66%
-5.94M
2023Q4
783
234.38M
108.27%
-1.28M
2023Q3
770
225.33M
104.20%
-18.20M
2023Q2
761
232.20M
107.41%
-2.78M
2023Q1
759
225.00M
104.19%
-1.65M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
28.62M
13.19%
+5.44M
+23.46%
Mar 31, 2025
The Vanguard Group, Inc.
23.51M
10.83%
+1.91M
+8.86%
Mar 31, 2025
William Blair Investment Management, LLC
13.56M
6.25%
-787.83K
-5.49%
Mar 31, 2025
Baillie Gifford & Co.
9.16M
4.22%
-590.13K
-6.05%
Mar 31, 2025
Gates Capital Management, Inc.
9.16M
4.22%
+9.16M
--
Mar 31, 2025
Norges Bank Investment Management (NBIM)
14.81M
6.82%
-2.67M
-15.27%
Mar 31, 2025
State Street Global Advisors (US)
8.61M
3.97%
+282.73K
+3.40%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
8.46M
3.9%
+1.34M
+18.89%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.44M
3.89%
+1.50M
+21.56%
Mar 31, 2025
Mackenzie Investments
7.76M
3.57%
-67.86K
-0.87%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sun, Jul 6
Aktualisiert: Sun, Jul 6
Name
Anteil
SPDR S&P Health Care Equipment ETF
1.51%
Invesco S&P SmallCap Health Care ETF
0.83%
iShares Emergent Food and AgTech Multisector ETF
0.62%
Federated Hermes MDT Small Cap Core ETF
0.28%
VanEck Agribusiness ETF
0.26%
WisdomTree US SmallCap Quality Growth Fund
0.22%
Invesco S&P SmallCap 600 Pure Value ETF
0.22%
Amplify Etho Climate Leadership U.S. ETF
0.22%
First Trust Multi-Manager Small Cap Opportunities ETF
0.18%
ProShares MSCI Transformational Changes ETF
0.17%
Mehr Anzeigen
SPDR S&P Health Care Equipment ETF
Anteil1.51%
Invesco S&P SmallCap Health Care ETF
Anteil0.83%
iShares Emergent Food and AgTech Multisector ETF
Anteil0.62%
Federated Hermes MDT Small Cap Core ETF
Anteil0.28%
VanEck Agribusiness ETF
Anteil0.26%
WisdomTree US SmallCap Quality Growth Fund
Anteil0.22%
Invesco S&P SmallCap 600 Pure Value ETF
Anteil0.22%
Amplify Etho Climate Leadership U.S. ETF
Anteil0.22%
First Trust Multi-Manager Small Cap Opportunities ETF
Anteil0.18%
ProShares MSCI Transformational Changes ETF
Anteil0.17%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
May 12, 2021
Split
1>2
Datum
Art
Verhältnis
May 12, 2021
Split
1>2
